CIK 0001385818 · Non-accelerated filer<br>Smaller reporting company
AYTU BIOPHARMA, INC
Sign in to watch- Ticker
- AYTU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 470883144
- Phone
- (720) 437-6580
- Business address
- 7900 E. UNION AVENUE, SUITE 920, DENVER, CO, 80237
- Former names
- AYTU BIOSCIENCE, INC, Rosewind CORP
- DEF 14A Proxy Proxy Statement
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement · Regulation FD disclosure
- 424B2 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Regulation FD disclosure
- UPLOAD Other SEC-generated Letter
- 10-K/A Report 10-K/A
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- SC 13G/A Stake Amended Statement of Ownership
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Regulation FD disclosure
- UPLOAD Other SEC-generated Letter
- 4 Grant or award Chief Financial Officer acquired 100,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
Page 13 of 46 · 907 filings